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Background/aim: To investigate cold-induced autoinflammatory syndrome 1 (CIAS1) gene polymorphisms that cause autoinflammatory
diseases in patients with nasal polyposis (NP).
Materials and methods: The study included 30 patients diagnosed with NP and 30 healthy age-matched individuals as a control group.
CIAS1 polymorphisms were assessed by DNA sequence analysis. Patients with nasal polyps and the control group were compared in
terms of gene polymorphisms. Each of the 8 polymorphisms of the CIAS1 gene was analyzed separately in the patient group.
Results: The most frequently observed polymorphisms in the patient group were c.732G > A in 83%, c.663C > T in 23%, and c.1308C
> A in 23% of the patients. c.732G > A polymorphism was evaluated separately. Guanine was transformed to adenine at the 732nd
nucleotide position of the CIAS1 gene in the cDNA of chromosome 1.
Conclusion: The CIAS1 gene c.732G > A polymorphism was thought to be responsible for an increase in disease susceptibility. The
frequency of the “A” allele is higher in the patient group compared to the control group. Autoinflammatory diseases seem like a candidate
to be one of these factors. This is the first report to define the role of autoinflammatory diseases among these factors.
Key words: Nasal polyps, hereditary autoinflammatory disease, polymorphism, inflammation, CIAS1

1. Introduction
Nasal polyposis (NP) is a chronic inflammatory disease of the
mucosa of the nose and the paranasal sinuses causing a stuffy
nose. Genetic features and environmental factors together
play a role in the development of nasal polyps (1). The role of
genetic factors in the etiology of chronic rhinosinusitis and
nasal polyps has been demonstrated with both clinical and
experimental studies (1–3).
Autoinflammatory diseases comprise a subgroup of
inflammatory diseases described recently. Cold induced
autoinflammatory syndrome 1 (CIAS1, NLRP3) is the most
frequent disorder in autoinflammatory diseases. Intermittent
autoinflammatory diseases have also been known as periodic
fever syndromes, which are characterized by recurrent
episodes of painful inflammation in the abdomen, chest, or
joints. These episodes are often accompanied by fever and
sometimes a rash. Systemic or localized signs of inflammation
accompany the fever attacks, and joint pain, headaches,
and ophthalmological and dermatological symptoms are

common. An increasing number of patients have been
diagnosed and treated since the definition of the disease at
the molecular level increased awareness in medical society.
CIAS1 gene mutations were first described in 2001 (4).
It is located on the first chromosome, and a mutation in
different parts of the CIAS1 gene may result in a variety of
diseases, namely familial cold autoinflammatory syndrome
(FCAS), Muckle–Wells syndrome (MWS), and chronic
infantile neurologic cutaneous arthropathy (CINCA) (4).
These 3 diseases demonstrate an autosomal dominant type
of inheritance. Recent studies have demonstrated the role of
this gene in the processing of interleukin (IL)-1-beta (5). In
this study we only targeted the third exon of the CIAS1 gene,
which is the largest among the 9 exons (56% of the coding
region) and comprises almost all the mutations reported so
far (90% of the mutations according to the Human Genome
Mutation Database).
The aim of this study was to define the etiology of
nasal polyposis and the possible associations with
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autoinflammatory diseases, which may present with a
variety of symptoms, and obtain new data on the etiology
and treatment of nasal polyposis. Common features of
autoinflammatory diseases are inflammation and edema.
Inflammation and edema in the nasal mucosa constitute
the main pathological condition in nasal polyposis, as well.
No reported studies were encountered when the
literature was analyzed for the association of nasal polyposis
and autoinflammatory diseases. The determination of
mutations related to many diseases is getting easier with
improvements in genetic testing, and thus the responsible
genes in some diseases have been defined.
In light of these data, the CIAS1 gene responsible
for FCAS, MWS, and CINCA was analyzed to define an
association between nasal polyposis and autoinflammatory
diseases.
2. Materials and methods
Patients who presented to the ENT outpatient clinic
of Ankara Numune Education and Research Hospital
who were diagnosed with nasal polyposis and a control
group that had no nasal polyposis were included in the
study. Patients were grouped homogeneously according
to sex and age. All patients were older than 18 years
of age. The diagnosis of nasal polyposis was made by
physical examination including endoscopic examination
and imaging studies (particularly by paranasal sinus
tomography).
Prior to the start of the study, ethical board approval
was obtained from the Evaluation Commission of the
Scientific Research of Ankara Numune Education and
Research Hospital. Informed consent was obtained from
all patients and from the control group.
All blood samples were taken from the antecubital veins
of the patients and placed into tubes containing disodium
ethylenediaminetetraacetic acid (3 mg/L). Blood samples
were stored at +4 °C until DNA extraction for 3 months.
Eight polymorphisms and all the mutations in the
third exon of the CIAS1 gene on the short arm of the first

chromosome were separately evaluated in all patients and
the control group.
2.1 Genotype identification
DNA isolations were performed by using QIAamp DNA
Blood Mini Kit (Qiagen Inc.) and stored at –20 °C until the
polymerase chain reaction (PCR) step.
CIAS1: To evaluate the mutations and polymorphisms
in the CIAS1 gene, primer design was performed for
exon number 3 and PCR amplification and Sanger
sequencing were carried out for each of the samples
to reveal the mutations and polymorphisms. Sanger
sequencing was carried out by using BigDye 3.1 chemistry
(Applied Biosystems Inc.) on an ABI 3130 capillary
electrophoresis instrument (Applied Biosystems Inc.) and
the electropherograms were analyzed with SeqScape 2.5
software (Applied Biosystems Inc.)
2.2 Statistical analysis
Statistical evaluations of the data obtained were performed
with SPSS for Windows 15.0. Chi-square and Fisher’s exact
tests were used in comparing the control and polyposis
groups. In addition, odds ratio and 95% confidence
intervals were given according to the alleles. The limit of
statistical significance was accepted as 0.05.
3. Results
A total of 60 samples, 30 with nasal polyposis and 30
without nasal polyposis, were included in the study. There
were 15 (50%) women and 15 (50%) men in the patient
group, while there were 15 (50%) women and 15 (50%)
men in the control group. The ages of the patients were
between 18 and 68 years, with a mean age of 43.3 years.
The age range of the control group was 18–64 years with a
mean age of 42.7 years.
Eight polymorphisms were detected in the CIAS1 gene
by Sanger sequencing and evaluated separately.
The results of CIAS1 gene polymorphisms of all
samples are listed in Table 1.
When the CIAS1 gene c.732G > A polymorphism was
evaluated separately, the frequency of the “A” allele was

Table 1. SNPs found in the cold induced autoinflammatory syndrome 1 (CIAS1) gene.
CIAS1 gene polymorphisms

SNP

Nasal polyposis

Control

Amino acid substitutions

1) c.663C > T

rs7525979

7 (23%)

4 (13%)

-

2) c.732G > A

rs3806268

25 (83%)

18 (60%)

-

3) c.786G > A

rs4925543

3 (10%)

4 (13.3%)

-

4) c.936C > T

rs143840033

1 (3%)

0

-

5) c.1038G > A

-

0

1 (3%)

-

6) c.1308C > T

rs34298354

7 (23%)

5 (16%)

-

7) c.2113C > A

rs35829419

4 (13%)

3 (10%)

Q705K

8) c.753C > T

-

0

1 (3%)

-
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higher in the patient group compared to the control group,
and this difference was found to be statistically significant
(OR, 2.252; CI, 1.084–4.678; P = 0.044) (Table 2).
The c.732 GA and AA genotypes were found more
frequently in the nasal polyposis group than in the controls.
This transformation could therefore be responsible for an
increase in disease susceptibility in genotypes GA and AA.
Homozygosity of the “A” allele of c.732G > A
polymorphism was observed in 10 of the NP patients
(33.3%) and 5 of the control group (16.7%). Thus,
homozygosity is twice as common in the patient group
compared to the controls, and the difference was found to
be statistically significant (OR, 4.8; CI, 1.074–21.447, P =
0.035).
Other polymorphisms in the CIAS1 gene were not
different in terms of homozygosity between the groups (P
< 0.05).
No statistically significant differences were found
between the patients with nasal polyposis and the control
group in the other 7 polymorphisms when they were
evaluated separately (P > 0.05).
When the MEFV gene polymorphisms were evaluated
separately, it was shown that there was no statistical
significant difference between the patient and control
groups (P > 0.05).
4. Discussion
Nasal polyposis is a disease that can be seen in almost all
age groups. Its incidence increases with age, peaking in
the fourth decade (6). The mean age of patients with nasal
polyposis in our study was 43.3 years. It is more common
in men. The male/female ratio is 2/1; it was 2.3/1 in this
study (7).
Although the etiology of nasal polyposis is not
completely revealed yet, genetic predisposition, infections,
anatomic variations, allergy, regional immunological
instability, and histological factors are thought to play a
role in the etiology.
Nasal polyposis is also a subject of many genetic
studies. Expressions of several genes were investigated by
qRT-PCR in patients with allergic rhinitis either with (3
patients) or without (4 patients) nasal polyposis in a study
by Fritz et al. They reported an increased incidence of the
mammaglobin gene in patients with nasal polyps when
they compared the results (8). However, the function of
the protein that is coded by this gene it is not clear, and is

thought to cause inflammation through its effect on the
epithelial secretory proteins (8).
Zielinska et al. reported that the 140 A/G polymorphism
of lactoferrin and the -33C/G polymorphism of osteoblast
specific factor 2, which has been thought to play a role in
the etiopathogenesis of nasal polyps, were seen more often
in patients with nasal polyposis (9).
Tumor necrosis factor-alpha (TNF-a) is a major
proinflammatory cytokine that exerts a range of important
inflammatory and immunomodulatory activities in host
defense. Batikhan et al. showed that TNF-a-308G > A
single nucleotide polymorphism (SNP) may play a role in
the etiology of nasal polyposis (10).
IL-6 orchestrates chronic inflammation and adaptive
immunity by regulating T-cell differentiation and
activation, inducing Th2 cytokine production. In another
study on the pathophysiology of nasal polyposis and
asthma, the IL-6-174G/C SNP GG genotype was found
more frequently in all nasal polyps and asthma groups
(11).
Cyclooxygenase-2 (COX-2) is induced during
inflammation, and takes an active part in the synthesis of
proinflammatory prostanoids. Mesenchymal–epithelial
transition factor (MET) is a transmembrane tyrosine
kinase receptor and a protooncogene. A recent study
showed that the -765G/C polymorphism of COX-2 gene
and the -14C/G polymorphism of MET gene may result
in an increased risk of developing nasal polyps in chronic
rhinosinusitis (12).
The human class II major histocompatibility complex
transactivator (CIITA) encodes a major histocompatibility
complex (MHC) class II transactivator and is essential for
MHC class II molecules. Lack of expression of the MHC
II gene is responsible for abnormal immune response and
immunodeficiency. Bae et al. reported the association
between CIITA variations and nasal polyposis. In that
study, it was found that rs12932187 and rs11074938 may
be susceptibility polymorphisms in nasal polyposis (13).
CD14 could have functional effects on the etiology of
allergies and asthma. C-159T SNP has been associated
with altered CD14 and IgE in patients with asthma and
allergic rhinitis. In a recent article, a significant association
between nasal polyp and C-159T was reported (14).
Cyclic nucleotide phosphodiesterases (PDEs) play
a role in signal transduction and inflammation. Four
genes encode a large number of PDE4 isoforms. PDE4D

Table 2. Genotype distribution of c.732G > A polymorphism.
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n

A allele

G allele

GG

GA

AA

Nasal polyp

30

58.3% (35/60)

41.7% (25/60)

5 (16.6%)

15 (50%)

10 (33.3%)

Control

30

38.3% (23/60)

61.7% (37/60)

12 (40%)

13 (43.3%)

5 (16.6%)
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(rs1588265) polymorphism was significantly higher in the
nasal polyp group than in the control group (15).
In our study, 8 polymorphisms and all the mutations
in the third exon of CIAS1 gene on the short arm of the
first chromosome were separately evaluated in all patients
and the control group. The “A” allele of CIAS1 c.732G >
A polymorphism in the nasal polyposis group was greater
than in the control group and the difference was found
to be statistically significant. When the 8 polymorphisms
in the CIAS1 gene in patients with nasal polyps were
evaluated together, it was found to be increased in the
patient group compared to the controls, though not
statistically significant.
The CIAS1 gene is responsible for the production of
proteins that play an important role in natural immunity
(16). Mutations in the fourth, sixth, and especially the
third exons of the CIAS1 gene have been demonstrated
(16–19). However, as in many genetic disorders,
environmental factors are also effective in the phenotype
of the disease, in addition to genetic factors (16–20). A
Swedish study reported increased activity of the CIAS1Q705K polymorphism as demonstrated by the increased
spontaneous and stimulated release of IL-1 beta and IL-18,
which are responsible in chronic inflammatory diseases
(21). In our study, Q705K polymorphism was detected
in 4 patients and 3 individuals in the study and control
groups, respectively. There were no statistically significant
differences in rs35829419 (Q705K) polymorphisms
between the nasal polyposis and control groups.

The etiology of nasal polyposis has not been fully
explained yet. The inflammatory process and the role of
inflammatory cells and mediators have been demonstrated
in many studies. Nasal polyposis and autoinflammatory
diseases are thought to be related in this study, and thus
polymorphisms in genes that produce autoinflammatory
diseases were investigated in patients with nasal polyps
and in individuals without nasal polyps as a control group.
All these data suggest that CIAS1 gene polymorphisms
are not a single cause of polyp formation, but can be
effective in the development of the disease. Indeed, polyp
formation is a multifactorial event and is thought to occur
with the presence of more than one factor. With this study,
the role of autoinflammatory diseases among these factors
is shown for the first time.
It is imperative to investigate relations with other
autoinflammatory diseases at this point.
The significant increase in the c.732G > A polymorphism
of the CIAS1 gene can lead to a treatment approach. Agents
used in the treatment of autoinflammatory diseases, such
as IL-1-beta receptor antagonists, IL-1-beta monoclonal
anticore, and rilonacept, might be used in the treatment
of nasal polyps in the future with the assistance of more
detailed studies.
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